Skip to main content
. 2002 Nov 26;87(12):1354–1359. doi: 10.1038/sj.bjc.6600644

Table 3. Commonly reported adverse events (occurring in ⩾6 out of 30 volunteers during screening or ⩾2 out of 10 during treatment).

graphic file with name 87-6600644t3.jpg